About
IOPtima Ltd. is a dynamic company focused on developing and commercializing innovative, minimally invasive ophthalmic devices. As a subsidiary of Chengdu Kanghong Pharmaceutical, IOPtima collaborates with global partners, including companies, researchers, and doctors, to enhance eye care for various ocular conditions. The company offers a range of products, including the IOPtimate® surgical system for glaucoma treatment, which utilizes CO2 laser technology to lower intraocular pressure. The iLid™ CO2 laser kit provides a precise alternative for oculoplasty procedures, while Lipitear™ Multi is a preservative-free, vegan microemulsion designed to alleviate dry eye symptoms. Additionally, IOPtima is developing the Fabilas™ surgical platform for high-precision ocular treatments. IOPtima targets ophthalmic surgeons, researchers, and healthcare providers, inviting partnerships to further advance ophthalmic treatment technologies. The company is committed to improving ophthalmic care through safe and effective solutions.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2005
-
Total Funding $7200000
Location
Leshem Street, Caesarea, Haifa District, Israel